Analytical Data
-
基因名
GAL3
- Application
-
别名
GAL3；GALNR3;Galanin receptor type 3
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P17931
-
表达区间
2-250aa
-
氨基酸序列
ADNFSLHDAL SGSGNPNPQG WPGAWGNQPA GAGGYPGASY PGAYPGQAPP GAYPGQAPPG AYPGAPGAYP GAPAPGVYPG PPSGPGAYPS SGQPSATGAY PATGPYGAPA GPLIVPYNLP LPGGVVPRML ITILGTVKPN ANRIALDFQR GNDVAFHFNP RFNENNRRVI VCNTKLDNNW GREERQSVFP FESGKPFKIQ VLVEPDHFKV AVNDAHLLQY NHRVKKLNEI SKLGISGDID LTSASYTMI
-
分子量
26.0 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GAL3, or Galactose-specific lectin 3, is a protein primarily expressed in mammals and plays a crucial role in various biological processes, including cell signaling, immune response, and tissue homeostasis. Its ability to bind specifically to galactose residues makes it significant in cell-cell interactions and the recognition of glycoproteins, which are often involved in pathological conditions like cancer and infectious diseases. The understanding of GAL3's function and mechanisms has been propelled by advancements in molecular biology and protein engineering strategies, leading to the production of recombinant GAL3 proteins. These studies have made it possible to elucidate GAL3's precise roles in cellular pathways and its interactions with various ligands. Furthermore, the manipulation of GAL3 expression and activity through recombinant technologies holds promise for developing novel therapeutic approaches and diagnostic tools, particularly in oncology and autoimmune disorders. Investigating the structure-function relationship of GAL3 provides valuable insights into its potential as a biomarker and therapeutic target, paving the way for innovative treatments in clinical settings.
